+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DelveInsight - Market Research Reports

Delve Insight authors market leading reports across the pharmaceutical and biotechnology sectors. The key findings and insights all come from regular monitoring of developments through the pharmaceutical and biotechnology sectors. These findings are then published through market forecasts, drug pipelines and drug insights, along with advice from top market analysts on how to best use this, alongside the detailed market forecasts offered by Delve Insight.

Sjogren's Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Sjogren's Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Chronic Spontaneous Urticaria - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Complicated Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Complicated Urinary Tract Infections - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Facioscapulohumeral Muscular Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Facioscapulohumeral Muscular Dystrophy - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Pneumococcal Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Pneumococcal Disease - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Acute Ischemic Stroke - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Ischemic Stroke - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Sodium Channel Blockers - Pipeline Insight, 2025 - Product Thumbnail Image

Sodium Channel Blockers - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 180 Pages
  • Global
From
Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2025 - Product Thumbnail Image

Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 280 Pages
  • Global
From
Graves' Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Graves' Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 60 Pages
  • Global
From
Batten Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Batten Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 60 Pages
  • Global
From
From
Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 60 Pages
  • Global
From
T-Cell Malignancies - Pipeline Insight, 2025 - Product Thumbnail Image

T-Cell Malignancies - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 280 Pages
  • Global
From
Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Breast Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 450 Pages
  • Global
From
Mucopolysaccharidosis Type I- Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis Type I- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Advanced Kidney Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Kidney Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
RAGE Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

RAGE Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Tendinopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Tendinopathy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Graves' Orbitopathy- Pipeline Insight, 2025 - Product Thumbnail Image

Graves' Orbitopathy- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Recessive Dystrophic Epidermolysis (RDEB) - Pipeline Insight, 2025 - Product Thumbnail Image

Recessive Dystrophic Epidermolysis (RDEB) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator